Journey Medical Corporation Q3 2026 Earnings Call Summary
B. Riley Securities Reiterates Buy on Journey Medical, Lowers Price Target to $13
Journey Medical (DERM) Q3 2026 Earnings Call Transcript
Journey Medical Corp (DERM) Q3 2026 Earnings Call Highlights: Emrosi Momentum Drives Revenue ...
What Journey Medical (DERM) Said on Its Q3 Earnings Call
Journey Medical (DERM) Reports Q3 Earnings: What Key Metrics Have to Say
Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates
Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Journey Medical Corporation (DERM) Q3 2026 Earnings Call Transcript
Journey Medical Q3 EPS $(0.05) Misses $(0.01) Estimate, Sales $18.967M Miss $20.321M Estimate
HC Wainwright & Co. Reiterates Buy on Journey Medical, Maintains $13 Price Target
Are Options Traders Betting on a Big Move in Journey Medical Stock?
Journey Medical: A Small Pharma With A Large Growth Opportunity
Journey Medical Corporation to Participate in September 2026 Investor Conferences
Journey Medical (DERM) Q2 2026 Earnings Call Transcript
Journey Medical: Q2 Report Confirms Thesis On Track As Emrosi Launch Gains Traction
B. Riley Securities Reiterates Buy on Journey Medical, Raises Price Target to $15
Journey Medical Corp (DERM) (Q2 2026) Earnings Call Highlights: Emrosi Surges 20% Sequentially, ...
Journey Medical Corporation Q2 2026 Earnings Call Summary
Journey Medical Q2 Earnings Call Highlights
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.